Unknown

Dataset Information

0

Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies.


ABSTRACT: Diabetic kidney disease (DKD) occurs in ∼40% of patients with diabetes and causes kidney failure, cardiovascular disease, and premature death. We analyzed the response of a murine DKD model to five treatment regimens using single-cell RNA sequencing (scRNA-seq). Our atlas of ∼1 million cells revealed a heterogeneous response of all kidney cell types both to DKD and its treatment. Both monotherapy and combination therapies targeted differing cell types and induced distinct and non-overlapping transcriptional changes. The early effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on the S1 segment of the proximal tubule suggest that this drug class induces fasting mimicry and hypoxia responses. Diabetes downregulated the spliceosome regulator serine/arginine-rich splicing factor 7 (Srsf7) in proximal tubule that was specifically rescued by SGLT2i. In vitro proximal tubule knockdown of Srsf7 induced a pro-inflammatory phenotype, implicating alternative splicing as a driver of DKD and suggesting SGLT2i regulation of proximal tubule alternative splicing as a potential mechanism of action for this drug class.

SUBMITTER: Wu H 

PROVIDER: S-EPMC9262852 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies.

Wu Haojia H   Gonzalez Villalobos Romer R   Yao Xiang X   Reilly Dermot D   Chen Tao T   Rankin Matthew M   Myshkin Eugene E   Breyer Matthew D MD   Humphreys Benjamin D BD  

Cell metabolism 20220615 7


Diabetic kidney disease (DKD) occurs in ∼40% of patients with diabetes and causes kidney failure, cardiovascular disease, and premature death. We analyzed the response of a murine DKD model to five treatment regimens using single-cell RNA sequencing (scRNA-seq). Our atlas of ∼1 million cells revealed a heterogeneous response of all kidney cell types both to DKD and its treatment. Both monotherapy and combination therapies targeted differing cell types and induced distinct and non-overlapping tra  ...[more]

Similar Datasets

2022-06-14 | GSE184652 | GEO
| PRJNA765580 | ENA
| S-EPMC8097156 | biostudies-literature
| S-EPMC4882276 | biostudies-literature
| S-EPMC10352247 | biostudies-literature
2025-01-07 | GSE209781 | GEO
| S-EPMC6450405 | biostudies-literature
| S-EPMC8415842 | biostudies-literature
| S-EPMC5398087 | biostudies-literature
| S-EPMC6293300 | biostudies-literature